Latest Articles

Publication Date
Effectiveness of BMMSC and Dienogest on IL-1β, IL-8 Expression and Lesion Area in Endometriosis Mice.

Endometriosis is a chronic estrogen-dependent inflammatory disease that impairs fertility and quality of life. Dienogest, the current standard therapy, provides symptom relief but does not correct immune imbalance or prevent …

Published: March 17, 2026, midnight
Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Letter].

Published: March 12, 2026, midnight
Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis.

Endometriosis (EMS) is characterized by pain symptoms that seriously affect patients' quality of life. Gut microbiome-related metabolites (GMRM) play an important role in the process of EMS. However, the role …

Published: Feb. 17, 2026, midnight
Phthalate Metabolite, Mono(2-Ethyl-5-Hydroxyhexyl) Phthalate (MEHHP), Promotes Uterine-Fibroid-Associated Phenotypes in Myometrial Stem Cell-Derived 3D Organoids.

This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2-ethylhexyl) phthalate, on myometrial stem cells …

Published: Feb. 1, 2026, midnight
Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells - openPR.com

Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells openPR.com

Published: Jan. 29, 2026, 7:48 a.m.
Cartherics secures second patent in China for TAG-72 CAR gene-Modified stem cell technology - BioMelbourne Network

Cartherics secures second patent in China for TAG-72 CAR gene-Modified stem cell technology BioMelbourne Network

Published: Jan. 29, 2026, 12:52 a.m.
Cartherics secures second patent in China for TAG-72 CAR gene-modified stem cell technology - BioMelbourne Network

Cartherics secures second patent in China for TAG-72 CAR gene-modified stem cell technology BioMelbourne Network

Published: Jan. 29, 2026, 12:52 a.m.
Targeting endometrial stem cell in endometriosis treatment, a scoping review.

Endometriosis is characterized by the ectopic implantation of endometrial tissue affecting reproductive-aged women. Available therapies have still unmet needs namely due to recurrence rates and systemic side effects. Emerging evidence …

Published: Jan. 20, 2026, midnight
Autologous CD133+ Stem Cells Trial for Asherman - BIOENGINEER.ORG

Autologous CD133+ Stem Cells Trial for Asherman BIOENGINEER.ORG

Published: Jan. 3, 2026, 7:41 a.m.
Autologous CD133+ Stem Cells Trial for Asherman - Bioengineer.org

Autologous CD133+ Stem Cells Trial for Asherman Bioengineer.org

Published: Jan. 3, 2026, 7:41 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!